The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial.
 
Rachel Abelman
No Relationships to Disclose
 
Shannon McLaughlin
Consulting or Advisory Role - Centaur Labs
 
Geoffrey Fell
No Relationships to Disclose
 
Ana Garrido-Castro
Honoraria - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Novartis; Pfizer
Research Funding - 4D Path (Inst); AstraZeneca (Inst); Biovica (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Foundation Medicine (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Precede Bio (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Merck; Novartis; Pfizer; Roche/Genentech
 
Filipa Lynce
Leadership - Alliance Foundation Trials
Consulting or Advisory Role - AmerisourceBergen; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Pfizer; Prime Education
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences; IDEAYA Biosciences; Incyte; Merck; Zentalis
 
Lorenzo Trippa
No Relationships to Disclose
 
Philip Poorvu
Other Relationship - Medscape
 
Aron Rosenstock
No Relationships to Disclose
 
Arielle Medford
Consulting or Advisory Role - AstraZeneca; Edgewood Oncology; Guardant Health; Illumina; Myriad Genetics; Natera; Novartis; Science for America
Speakers' Bureau - Natera
Research Funding - AstraZeneca (Inst)
 
Seth Wander
Consulting or Advisory Role - AstraZeneca; Biovica; Foundation Medicine; Genentech/Roche; Hologic; Lilly; Novartis; Pfizer; Puma Biotechnology; Regor Therapeutics; Veracyte
Speakers' Bureau - 2nd.MD; Guardant Health; Lilly
Research Funding - Genentech; Lilly; Nuvation Bio; Pfizer; Regor Therapeutics; Sermonix Pharmaceuticals
 
Amy Comander
Consulting or Advisory Role - Advance Medical; Applied Genetic Technologies Corporation (I); Beam Therapeutics (I); Biogen (I); Blue Cross Blue Shield Association (I); Crico; Editas Medicine (I); GenSight Biologics (I); Harvard Medical School; infiniteMD (I); Sanofi (I); Vedere Bio (I); WAVE Life Sciences (I)
 
Steven Isakoff
Employment - Merus (I)
Stock and Other Ownership Interests - Merus NV (I)
Consulting or Advisory Role - Veracyte
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Genentech (Inst); Merck (Inst); OncoPep (Inst)
 
Beverly Moy
Consulting or Advisory Role - HRA Pharma
 
Nadine Tung
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst)
 
Elizabeth Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Alight Sciences; AstraZeneca; AstraZeneca; BioNTech SE; Merck; Merck; Moderna Therapeutics
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck Sharpe and Dohme
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Roche/Genentech
 
Leif Ellisen
Consulting or Advisory Role - AstraZeneca; Atavistik; Gilead Sciences; KisoJi Biotechnology; mersana
Research Funding - Eisai (Inst); Sanofi (Inst)
 
Sara Tolaney
Consulting or Advisory Role - AADi; Ambrx; Artios Biopharmaceuticals; Arvinas; AstraZeneca; Bayer; BeiGene; Bicycle Therapeutics; BioNTech; Blueprint Medicines; Bristol-Myers Squibb; Circle Pharma; Cullinan Oncology; Daiichi Sankyo; eFFECTOR Therapeutics; Eisai; Genentech; Hengrui Pharmaceutical (USA); Immunomedics/Gilead; Incyte; Jazz Pharmaceuticals; Johnson & Johnson; Launch Therapeutics; Lilly; Menarini Group; Merck; Mersana; Natera; Novartis; Pfizer; Reveal Genomics; Sanofi; Seagen; Sumitovant Biopharma; Summit Therapeutics; Systimmune; Tango Therapeutics; Zentalis; Zuellig Pharma; Zymeworks
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo; Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Menarini/Stemlin (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Arvinas; Gilead Sciences; Jazz Pharmaceuticals; Lilly; Pfizer; Sanofi
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Gilead Sciences
 
Aditya Bardia
Consulting or Advisory Role - Alyssum; Daiichi Sankyo/Astra Zeneca; Genentech; Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly; Lilly (Inst); Menarini; Menarini (Inst); Merck; Mersana; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health (Inst); Sanofi
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)
 
Laura Spring
Consulting or Advisory Role - AstraZeneca; Daiichi Pharma; G1 Therapeutics; Lilly; Novartis; Precede Bio; Seagen
Research Funding - Genentech/Roche; Gilead Sciences; Lilly; Merck (Inst)